Advances in Medical Sciences

Papers
(The H4-Index of Advances in Medical Sciences is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Response to Letter to the Editor on “Incidence of atrial fibrillation in pregnancy and clinical significance: A meta-analysis”78
Pulmonary function, exercise capacity and dyspnea in patients 7 ​years after Nuss surgery47
Investigation of circulating natural autoantibodies against ANXA1 and MYC as potential biomarkers in hepatocellular carcinoma43
Inhibition of TRPM7 by glutathione decreases oxidant and apoptotic action of cisplatin through the downregulation of Ca2+ and Zn2+ in glioblastoma cells38
Editorial Board33
Effects of intensity-modulated radiotherapy combined with chemotherapy and prognostic factors in patients with locally advanced oesophageal cancer29
Potential of the postoperative lymphocyte-to-monocyte and monocyte-to-red blood cell ratio in predicting locoregional and distant metastases after breast cancer resection - Retrospective study25
Corrigendum to “Genome-engineering technologies for modeling and treatment of cystic fibrosis” [Adv Med Sci (2023 Sept) 68(1) 111–120]24
Periodontal disease in patients with thyroid diseases: A systematic review with meta-analysis22
Immunization with placenta-specific 1 (plac1) induces potent anti-tumor responses and prolongs survival in a mouse model of melanoma20
Anti-ETAR and suPAR as markers of disease activity in renal ANCA-associated vasculitis19
Clinical impact of brachyury expression in Ewing sarcoma patients16
Reducing metastasis ability of gastric cancer cell line by targeting MMP16 using miR-193a-5p and 5-FU15
Trimethylamine N-oxide as a potential prognostic biomarker for mortality in patients with COVID-19 disease15
Patterned edge-illuminated display for clinical examination of visual evoked potentials using simultaneous magnetic resonance imaging15
LRRC45 promotes lung cancer proliferation and progression by enhancing c-MYC, slug, MMP2, and MMP9 expression15
0.058182001113892